Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Franco M Muggia

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Anti-Cancer Drugs|January 25, 2003
A phase I study of paclitaxel, estramustine phosphate and vinorelbine (Pacl-E-Vin) in advanced malignancies: triple tubulin targetingSanjeev Sewak, Abraham Chachoua, Anne Hamilton, et al.
Journal of Clinical Medicine|May 30, 2019
Decreasing Trends of Secondary Primary Colorectal Cancer among Women with Uterine Cancer: A Population-Based AnalysisKoji Matsuo, Rachel S Mandelbaum, Hiroko Machida, et al.
The Laryngoscope|December 5, 2019
Oral Squamous Cell Carcinoma as a Complication of Treatment for Recurrent High-Grade Serous CancerLindsey E Moses, Janine M Rotsides, Fiyinfolu O Balogun, et al.
Gynecologic Oncology|May 28, 2019
Decreasing secondary primary uterine cancer after breast cancer: A population-based analysisKoji Matsuo, Rachel S Mandelbaum, Hiroko Machida, et al.
Gynecologic Oncology|February 10, 2004
Evaluation of vinorelbine in persistent or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group studyFranco M Muggia, John A Blessing, Michael Method, et al.
Gynecologic Oncology|December 14, 2004
Evaluation of vinorelbine in persistent or recurrent nonsquamous carcinoma of the cervix: a Gynecologic Oncology Group StudyFranco M Muggia, John A Blessing, Steven Waggoner, et al.
Archives of Gynecology and Obstetrics|March 3, 2019
Efficacy of pegylated liposomal doxorubicin maintenance therapy in platinum-sensitive recurrent epithelial ovarian cancer: a retrospective studyErin A Blake, Chrystal A Bradley, Sayedamin Mostofizadeh, et al.
The Oncologist|November 2, 2014
Chronic thalidomide and chemoembolization for hepatocellular carcinomaJennifer Wu, Jennifer Ng, Paul J Christos, et al.
Archives of Gynecology and Obstetrics|March 25, 2020
Temporal trends of subsequent breast cancer among women with ovarian cancer: a population-based studyKoji Matsuo, Rachel S Mandelbaum, Hiroko Machida, et al.
Gynecologic Oncology|December 7, 2002
Correlation of p53 immunostaining in primary and residual ovarian cancer at the time of positive second-look laparotomy and its prognostic role: a Southwest Oncology Group ancillary studyDebra Hawes, P Y Liu, Franco M Muggia, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Anti-Cancer Drugs|January 25, 2003
A phase I study of paclitaxel, estramustine phosphate and vinorelbine (Pacl-E-Vin) in advanced malignancies: triple tubulin targetingSanjeev Sewak, Abraham Chachoua, Anne Hamilton, et al.
Journal of Clinical Medicine|May 30, 2019
Decreasing Trends of Secondary Primary Colorectal Cancer among Women with Uterine Cancer: A Population-Based AnalysisKoji Matsuo, Rachel S Mandelbaum, Hiroko Machida, et al.
The Laryngoscope|December 5, 2019
Oral Squamous Cell Carcinoma as a Complication of Treatment for Recurrent High-Grade Serous CancerLindsey E Moses, Janine M Rotsides, Fiyinfolu O Balogun, et al.
Gynecologic Oncology|May 28, 2019
Decreasing secondary primary uterine cancer after breast cancer: A population-based analysisKoji Matsuo, Rachel S Mandelbaum, Hiroko Machida, et al.
Gynecologic Oncology|February 10, 2004
Evaluation of vinorelbine in persistent or recurrent squamous cell carcinoma of the cervix: a Gynecologic Oncology Group studyFranco M Muggia, John A Blessing, Michael Method, et al.
Gynecologic Oncology|December 14, 2004
Evaluation of vinorelbine in persistent or recurrent nonsquamous carcinoma of the cervix: a Gynecologic Oncology Group StudyFranco M Muggia, John A Blessing, Steven Waggoner, et al.
Archives of Gynecology and Obstetrics|March 3, 2019
Efficacy of pegylated liposomal doxorubicin maintenance therapy in platinum-sensitive recurrent epithelial ovarian cancer: a retrospective studyErin A Blake, Chrystal A Bradley, Sayedamin Mostofizadeh, et al.
The Oncologist|November 2, 2014
Chronic thalidomide and chemoembolization for hepatocellular carcinomaJennifer Wu, Jennifer Ng, Paul J Christos, et al.
Archives of Gynecology and Obstetrics|March 25, 2020
Temporal trends of subsequent breast cancer among women with ovarian cancer: a population-based studyKoji Matsuo, Rachel S Mandelbaum, Hiroko Machida, et al.
Gynecologic Oncology|December 7, 2002
Correlation of p53 immunostaining in primary and residual ovarian cancer at the time of positive second-look laparotomy and its prognostic role: a Southwest Oncology Group ancillary studyDebra Hawes, P Y Liu, Franco M Muggia, et al.
Pageof 6